Bausch Health Cos Revenue 2012-2025 | BHC
Bausch Health Cos revenue from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Bausch Health Cos Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $10,266 |
| 2024 | $9,625 |
| 2023 | $8,757 |
| 2022 | $8,124 |
| 2021 | $8,434 |
| 2020 | $8,027 |
| 2019 | $8,601 |
| 2018 | $8,380 |
| 2017 | $8,724 |
| 2016 | $9,674 |
| 2015 | $10,447 |
| 2014 | $8,206 |
| 2013 | $5,770 |
| 2012 | $3,480 |
| 2011 | $2,427 |
|
Bausch Health Cos Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-12-31 | $2,796 |
| 2025-09-30 | $2,681 |
| 2025-06-30 | $2,530 |
| 2025-03-31 | $2,259 |
| 2024-12-31 | $2,559 |
| 2024-09-30 | $2,510 |
| 2024-06-30 | $2,403 |
| 2024-03-31 | $2,153 |
| 2023-12-31 | $2,408 |
| 2023-09-30 | $2,238 |
| 2023-06-30 | $2,167 |
| 2023-03-31 | $1,944 |
| 2022-12-31 | $2,193 |
| 2022-09-30 | $2,046 |
| 2022-06-30 | $1,967 |
| 2022-03-31 | $1,918 |
| 2021-12-31 | $2,196 |
| 2021-09-30 | $2,111 |
| 2021-06-30 | $2,100 |
| 2021-03-31 | $2,027 |
| 2020-12-31 | $2,213 |
| 2020-09-30 | $2,138 |
| 2020-06-30 | $1,664 |
| 2020-03-31 | $2,012 |
| 2019-12-31 | $2,224 |
| 2019-09-30 | $2,209 |
| 2019-06-30 | $2,152 |
| 2019-03-31 | $2,016 |
| 2018-12-31 | $2,121 |
| 2018-09-30 | $2,136 |
| 2018-06-30 | $2,128 |
| 2018-03-31 | $1,995 |
| 2017-12-31 | $2,163 |
| 2017-09-30 | $2,219 |
| 2017-06-30 | $2,233 |
| 2017-03-31 | $2,109 |
| 2016-12-31 | $2,403 |
| 2016-09-30 | $2,479 |
| 2016-06-30 | $2,420 |
| 2016-03-31 | $2,372 |
| 2015-12-31 | $2,758 |
| 2015-09-30 | $2,787 |
| 2015-06-30 | $2,732 |
| 2015-03-31 | $2,170 |
| 2014-12-31 | $2,223 |
| 2014-09-30 | $2,056 |
| 2014-06-30 | $2,041 |
| 2014-03-31 | $1,886 |
| 2013-12-31 | $2,064 |
| 2013-09-30 | $1,542 |
| 2013-06-30 | $1,096 |
| 2013-03-31 | $1,068 |
| 2012-12-31 | $920 |
| 2012-09-30 | $884 |
| 2012-06-30 | $820 |
| 2012-03-31 | $856 |
| 2011-12-31 | $652 |
| 2011-09-30 | $601 |
| 2011-06-30 | $609 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.086B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |